We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

床旁测定用唾液样本诊断呼吸道病毒

By LabMedica International staff writers
Posted on 01 Aug 2018
Print article
图片:Xpert Xpress流感/RSV测定盒(图片蒙Cepheid公司惠赐)。
图片:Xpert Xpress流感/RSV测定盒(图片蒙Cepheid公司惠赐)。

有人提议用唾液作为样本检测呼吸道病毒,替代鼻咽抽吸物或鼻咽拭子样本:唾液的优势为引起患者的不适较轻,对医疗工作者造成的风险更小。

 

自动化床旁分子测定极大缩短了呼吸道病毒化验的运行时间。现在的主要瓶颈之一是样本收集这一步,尤其是在繁忙的临床场合。唾液是一种方便的样本,成人患者可轻松获取。

 

香港大学(www.hku.hk)的科学家在2017710月间招募了214名患者,并开展了一项前瞻性诊断确证研究,用美国加利福尼亚州森尼韦尔市Cepheid公司(www.cepheid.com)Xpert Xpress流感/RSV产品检测住院成人患者的唾液和鼻咽抽吸物(NPA),比较两者对呼吸道病毒的检测率。还估计了收集唾液与鼻咽样本所需的成本和时间。

 

科研小组发现,唾液与NPA之间的总体一致率为93.3% (196/210)。二者检测呼吸道病毒的检测率无显著差异,前者为69/210 (32.9%),后者为75/210 (35.7%)。唾液的总灵敏度与特异性分别为90.8% (81.9-96.2%)100% (97.3-100%)NPA的总灵敏度与特异性分别为96.1% (88.9-99.2%)98.5% (94.7-99.8%)。收集NPA的时间与成本分别是收集唾液的时间与成本的2.3倍和2.6倍。

 

该研究的论文发表于2018612日的《临床微生物学与传染》(Clinical Microbiology and Infection)杂志。作者总结说,这款自动化多重床旁分子测定获得了临床实验室改进修正案(CLIA)标准的豁免权,使用唾液样本检测呼吸道病毒的灵敏度与特异性高于NPA。使用唾液还缩短了收集样本所需时间,降低了成本。

Related Links:

香港大学>>> www.hku.hk

Cepheid >>> www.cepheid.com


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more